Kirsty McCarthy

Kirsty McCarthy

Chief Operating Officer

Kirsty brings over 25 years of experience in tech and biotech commercialization to the team. Kirsty is a Co-Founder of both Pathios Therapeutics, an early stage biotechnology company and, Molecule 2 Medicine, which is a UK based consulting firm assisting global clients with the discovery, development and commercialisation of new human therapeutics, including new company formation and associated activities. From 2004-2010, she was Director and CEO of various technology ventures focused in the speech recognition and AI space. She holds a BA from University of Queensland, completed her honours year at Monash University, Australia and her MBA at the University of Melbourne.